Correction: NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker

Mod Pathol. 2020 Oct;33(10):2087. doi: 10.1038/s41379-020-0570-8.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

  • Published Erratum